Levodopa → HCID 178517985, 화합물

HRID 46058

반응식

HRID 46058 반응식
N[C@@H:2]([CH2:6][C:7]1[CH:12]=[CH:11][C:10]([OH:13])=[C:9]([OH:14])[CH:8]=1)[C:3]([OH:5])=O.[CH:15]1([NH:22][C:23]([NH2:25])=[S:24])[CH2:21][CH2:20][CH2:19][CH2:18][CH2:17][CH2:16]1>>[CH:15]1([NH:22][C:23]2[S:24][CH:2]([CH2:6][C:7]3[CH:12]=[CH:11][C:10]([OH:13])=[C:9]([OH:14])[CH:8]=3)[C:3](=[O:5])[N:25]=2)[CH2:21][CH2:20][CH2:19][CH2:18][CH2:17][CH2:16]1

참가 물질

3

반응물 2

HCID 6047LevodopaHCID 13433274N-Cycloheptylthiourea

생성물 1

HCID 178517985HCID 178517985, 화합물

실험 절차

Synthesis was performed from (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid and N-cycloheptylthiourea according to Method E and C.

후처리

  1. customSynthesis

출처 및 근거

ORD 기록
ord-6171155ec9164f7f825a8bcc33cca894
출처 데이터셋
uspto-grants-2013_09
특허 번호
US08541592B2

연결된 노트

불러오는 중…